The authors note that semaglutide had a holistic therapeutic approach to both liver disease and associated cardiometabolic illnesses. These results lend further credence that semaglutide is the Swiss army knife of medicine we have been looking for, to treat obesity, cardiovascular disease, type 2 diabetes, and now MASH, Beverly Tchang, MD, an endocrinologist and assistant professor of clinical medicine at Weill Cornell Medicine, not affiliated with the trial, told Healthline.
Chang L, Kahler KH, Sarawate C, Quimbo R, Kralstein J
Retrieved from Blundell, J., Finlayson, G., Axelsen, M., et al
This program delivered! Kim T